• News Review
  • Posted in News Review

  • 30th Jan 2013

  • Marketing Authorisation extension for Gadovist® 1.0 (gadobutrol) in the whole body Bayer HealthCare’s Radiology and Interventional division has completed the necessary UK variation procedure for Gadovist®1.0 (gadobutrol) for the diagnosis of diseases in the whole body with magnetic resonance imaging. Based on the label extension, Gadovist 1.0 can be used in Europe for magnetic resonance […]


Open Access, for medical professionals: Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified. 

We may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time.

See a sample email newsletter here
This website is for medical professionals only.